Clinical Trials Directory

Trials / Completed

CompletedNCT00483665

Vasovist Endoleak Study

Detection of Endoleak by Vasovist-Enhanced Magnetic Resonance Imaging

Status
Completed
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
UMC Utrecht · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

After endovascular treatment of an abdominal aortic aneurysm, lifelong imaging follow-up is needed to monitor the effectiveness of the treatment. One parameter in this follow-up is endoleak, which is leakage of blood into the aneurysm sac. The aim of this study is to investigate the value of magnetic resonance imaging using Vasovist as a contrast agent for the detection of endoleaks.

Detailed description

After endovascular abdominal aortic aneurysm repair, life-long follow-up is needed to monitor the effectiveness of exclusion of the aneurysm sac from blood flow. For this reason, aneurysm diameter and the presence of endoleaks is evaluated with computed tomographic (CT) angiography yearly after Endovascular Aneurysm Repair (EVAR). The aim of this study is to investigate the value of magnetic resonance imaging using Vasovist as a contrast agent for the detection of endoleaks. The advantages of magnetic resonance imaging with respect to CTA are no use of ionizing radiation, use of less nephrotoxic contrast agents.

Conditions

Interventions

TypeNameDescription
PROCEDUREComputed tomography angiographyComputed tomography angiography
PROCEDUREMagnetic resonance imagingMagnetic resonance imaging after injection of Vasovist

Timeline

Start date
2006-06-01
First posted
2007-06-07
Last updated
2008-11-19

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00483665. Inclusion in this directory is not an endorsement.

Vasovist Endoleak Study (NCT00483665) · Clinical Trials Directory